BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 31801816)

  • 1. Activation of TCR Vδ1
    Rutishauser T; Lepore M; Di Blasi D; Dangy JP; Abdulla S; Jongo S; Ramadhani K; Sim BKL; Hoffman SL; Tanner M; Daubenberger C; De Libero G
    J Immunol; 2020 Jan; 204(1):180-191. PubMed ID: 31801816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic changes of γδ T cells in
    Nana CMM; Tchakounté BDK; Bitye BMZ; Fogang B; Zangue BKT; Seumko'o RMN; Nana BC; Leke RGF; Djontu JC; Argüello RJ; Ayong L; Megnekou R
    Front Immunol; 2024; 15():1385380. PubMed ID: 38827744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Vδ1
    Hviid L; Smith-Togobo C; Willcox BE
    Front Immunol; 2019; 10():259. PubMed ID: 30837999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of human Pegivirus infections in whole Plasmodium falciparum sporozoite vaccination and controlled human malaria infection in African volunteers.
    Tumbo AM; Schindler T; Dangy JP; Orlova-Fink N; Bieri JR; Mpina M; Milando FA; Juma O; Hamad A; Nyakarungu E; Chemba M; Mtoro A; Ramadhan K; Olotu A; Makweba D; Mgaya S; Stuart K; Perreau M; Stapleton JT; Jongo S; Hoffman SL; Tanner M; Abdulla S; Daubenberger C
    Virol J; 2021 Jan; 18(1):28. PubMed ID: 33499880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal analysis of gamma delta T cell subsets during malaria infections in Malian adults.
    Diallo H; Katile A; Kwan JL; Sissoko MS; Healy SA; Doumbo OK; Duffy PE; Zaidi I
    Malar J; 2019 Mar; 18(1):69. PubMed ID: 30866943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptor expression and function in subsets of human gammadelta T lymphocytes.
    Pietschmann K; Beetz S; Welte S; Martens I; Gruen J; Oberg HH; Wesch D; Kabelitz D
    Scand J Immunol; 2009 Sep; 70(3):245-55. PubMed ID: 19703014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection.
    Lyke KE; Ishizuka AS; Berry AA; Chakravarty S; DeZure A; Enama ME; James ER; Billingsley PF; Gunasekera A; Manoj A; Li M; Ruben AJ; Li T; Eappen AG; Stafford RE; Kc N; Murshedkar T; Mendoza FH; Gordon IJ; Zephir KL; Holman LA; Plummer SH; Hendel CS; Novik L; Costner PJ; Saunders JG; Berkowitz NM; Flynn BJ; Nason MC; Garver LS; Laurens MB; Plowe CV; Richie TL; Graham BS; Roederer M; Sim BK; Ledgerwood JE; Hoffman SL; Seder RA
    Proc Natl Acad Sci U S A; 2017 Mar; 114(10):2711-2716. PubMed ID: 28223498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled Human Malaria Infection Leads to Long-Lasting Changes in Innate and Innate-like Lymphocyte Populations.
    Mpina M; Maurice NJ; Yajima M; Slichter CK; Miller HW; Dutta M; McElrath MJ; Stuart KD; De Rosa SC; McNevin JP; Linsley PS; Abdulla S; Tanner M; Hoffman SL; Gottardo R; Daubenberger CA; Prlic M
    J Immunol; 2017 Jul; 199(1):107-118. PubMed ID: 28576979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Vδ1 γδ T cells expanded from peripheral blood exhibit specific cytotoxicity against B-cell chronic lymphocytic leukemia-derived cells.
    Siegers GM; Dhamko H; Wang XH; Mathieson AM; Kosaka Y; Felizardo TC; Medin JA; Tohda S; Schueler J; Fisch P; Keating A
    Cytotherapy; 2011 Jul; 13(6):753-64. PubMed ID: 21314241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated
    von Borstel A; Chevour P; Arsovski D; Krol JMM; Howson LJ; Berry AA; Day CL; Ogongo P; Ernst JD; Nomicos EYH; Boddey JA; Giles EM; Rossjohn J; Traore B; Lyke KE; Williamson KC; Crompton PD; Davey MS
    Sci Transl Med; 2021 Dec; 13(622):eabe7430. PubMed ID: 34851691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expansion of Functional Myeloid-Derived Suppressor Cells in Controlled Human Malaria Infection.
    Lamsfus Calle C; Fendel R; Singh A; Richie TL; Hoffman SL; Kremsner PG; Mordmüller B
    Front Immunol; 2021; 12():625712. PubMed ID: 33815377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety, Immunogenicity, and Protective Efficacy against Controlled Human Malaria Infection of
    Jongo SA; Shekalaghe SA; Church LWP; Ruben AJ; Schindler T; Zenklusen I; Rutishauser T; Rothen J; Tumbo A; Mkindi C; Mpina M; Mtoro AT; Ishizuka AS; Kassim KR; Milando FA; Qassim M; Juma OA; Mwakasungula S; Simon B; James ER; Abebe Y; Kc N; Chakravarty S; Saverino E; Bakari BM; Billingsley PF; Seder RA; Daubenberger C; Sim BKL; Richie TL; Tanner M; Abdulla S; Hoffman SL
    Am J Trop Med Hyg; 2018 Aug; 99(2):338-349. PubMed ID: 29943719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocyte activation and subset redistribution in the peripheral blood in acute malaria illness: distinct gammadelta+ T cell patterns in Plasmodium falciparum and P. vivax infections.
    Worku S; Björkman A; Troye-Blomberg M; Jemaneh L; Färnert A; Christensson B
    Clin Exp Immunol; 1997 Apr; 108(1):34-41. PubMed ID: 9097908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human gamma delta T cells that inhibit the in vitro growth of the asexual blood stages of the Plasmodium falciparum parasite express cytolytic and proinflammatory molecules.
    Troye-Blomberg M; Worku S; Tangteerawatana P; Jamshaid R; Söderström K; Elghazali G; Moretta L; Hammarström M; Mincheva-Nilsson L
    Scand J Immunol; 1999 Dec; 50(6):642-50. PubMed ID: 10607313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Vγ9Vδ2 T Lymphocytes in the Immune Response to
    Howard J; Zaidi I; Loizon S; Mercereau-Puijalon O; Déchanet-Merville J; Mamani-Matsuda M
    Front Immunol; 2018; 9():2760. PubMed ID: 30538708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct venous inoculation of Plasmodium falciparum sporozoites for controlled human malaria infection: a dose-finding trial in two centres.
    Mordmüller B; Supan C; Sim KL; Gómez-Pérez GP; Ospina Salazar CL; Held J; Bolte S; Esen M; Tschan S; Joanny F; Lamsfus Calle C; Löhr SJ; Lalremruata A; Gunasekera A; James ER; Billingsley PF; Richman A; Chakravarty S; Legarda A; Muñoz J; Antonijoan RM; Ballester MR; Hoffman SL; Alonso PL; Kremsner PG
    Malar J; 2015 Mar; 14():117. PubMed ID: 25889522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective activation of TCR-gammadelta+ cells in endemic Burkitt's lymphoma.
    Futagbi G; Welbeck JE; Tetteh JK; Hviid L; Akanmori BD
    Malar J; 2007 May; 6():69. PubMed ID: 17521425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of Plasmodium falciparum erythrocytic cycle: γδ T cells target the red blood cell-invasive merozoites.
    Costa G; Loizon S; Guenot M; Mocan I; Halary F; de Saint-Basile G; Pitard V; Déchanet-Merville J; Moreau JF; Troye-Blomberg M; Mercereau-Puijalon O; Behr C
    Blood; 2011 Dec; 118(26):6952-62. PubMed ID: 22045985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristics of γδ T cell subsets induced from peripheral blood mononuclear cells of HIV/AIDS patients in vitro].
    Chen WW; Wu XL; Nie WM; Xie YX; Wang L; Zhao M
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Mar; 28(3):285-7. PubMed ID: 22394638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human liver infiltrating γδ T cells are composed of clonally expanded circulating and tissue-resident populations.
    Hunter S; Willcox CR; Davey MS; Kasatskaya SA; Jeffery HC; Chudakov DM; Oo YH; Willcox BE
    J Hepatol; 2018 Sep; 69(3):654-665. PubMed ID: 29758330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.